Kontafarma China Holdings Ltd (1312.HK) HKSE

0.03

-0.001(-3.45%)

Updated at December 24 11:51AM

Currency In HKD

Valuation

Market Cap145.05M
Enterprise Value361.65M
P/E Ratio-0.43
PEG Ratio0
Price/Sales Ratio0.17
Price/Book Ratio0.23
Enterprise/Revenue0.35
Enterprise/EBITDA-3.96

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.41
Operating Margin-0.26

Management Effectiveness

Return On Assets-0.31
Return On Equity-0.44

Income Statement

Revenue897.52M
Revenue/Share0.16
Gross Profit516.16M
EBITDA-49.93M
Net Income-75.54M
Diluted EPS-0.01

Balance Sheet

Total Cash78.33M
Total Cash/Share0.01
Total Debt235.86M
Total Debt/Equity0.34
Current Ratio1.02
Book Value Per Share0.11

Price History

52-Week Change3.7
52-Week High0.05
52-Week Low0.02
Moving Average 50 Days0.03
Moving Average 200 Days0.03

Statistics

Average Volume2.58M
Shares Outstanding5.57B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor5:1
Last Split DateFebruary 03, 2015